Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
GLUCOCORTICOID DOSE IS PROGRESSIVELY REDUCED IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING SARILUMAB: RESULTS FROM THE OPEN-LABEL EXTEND STUDY Fleischmann, R., Selmi, C., Gonzalez-Gay, M., van Hoogstraten, H., Hagino, O., Rajput, T., St John, G., Buttgereit, F., Genovese, M. C. LIPPINCOTT WILLIAMS & WILKINS. 2020: 80
View details for Web of Science ID 000530661500220